MRNA
xyz:
equity
· Hyperliquid
—
Equity perp — Hyperliquid synthetic derivative. For real-time exchange pricing, turn off the Crypto toggle and search the bare equity ticker.
Equity perpetual — synthetic exposure to a stock without owning the share. Hyperliquid orchestrates funding to keep mark close to the underlying. Trades 24/7 unlike the underlying.
Mark Price
$202.16
24h Change
+2.50%
Funding (8h)
+0.0046%
Open Interest
27,971
24h Volume
$1.41M
Oracle Price
$201.94
Mark − Oracle
+0.1221%
Prev Day Close
$197.22
As of (UTC)
2026-11-21 21:46:45
Daily candles — last 91 days
Funding rate history — last 7 days (8h cycles)
Positive funding = longs paying shorts (long-crowded). Negative = shorts paying longs (short-crowded).
Peers — same category
| Coin | Mark | 24h % |
|---|---|---|
| NVDA | $131.25 | +2.28% |
| ANT | $89.95 | +1.87% |
| SOXL | $33.09 | +0.60% |
| MU | $611.31 | +1.07% |
| SKHX | $764.86 | +1.92% |
News headlines Yahoo Finance, 1h cache
-
Learn Why The Bull Case For Moderna (MRNA) Could Change Following Melanoma Vaccine Trial Results
2026-11-21 06:09 · Yahoo
-
Moderna (MRNA) Lands March 2027 PBAC Slot For mRNA Flu Vaccine Listings
2026-11-21 05:14 · Yahoo
-
What A Cancer Vaccine Stumble Means For Moderna Stock
2026-11-20 18:29 · Yahoo
-
1 High-Flying Stock to Buy Hand Over Fist if the Stock Market Crashes
2026-11-20 17:41 · Yahoo
-
This $8 pharma stock is up 52%—and still trades at 1.6x earnings
2026-11-20 13:48 · Yahoo
-
Moderna vs. BioNTech: Why Only 1 Is a Buy Heading Into 2027
2026-11-20 09:15 · Yahoo
-
Moderna: Can the Vaccine Business Fund Its Next Phase of Growth?
2026-11-19 17:17 · Yahoo
-
Bireme Capital Sold Moderna (MRNA) Following Record Rally
2026-11-19 15:56 · Yahoo
-
Moderna Just Dropped 17% in a Week as 2027 Cash Costs Head to $4 Billion. Time to Sell, or Load Up?
2026-11-19 11:25 · Yahoo
-
While Moderna sank 17%, this generic drugmaker quietly jumped 64%
2026-11-19 09:27 · Yahoo